Breathing muscle training and thinking ability study
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether training the muscles you use to breathe in can help improve thinking and memory. It's for people with mild to moderate cognitive changes who are on stable medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Score between 18 and 28 on a memory and thinking test (MMSE)
- Taking stable medications for your condition (no recent changes)
- No current psychological disorder
- No medical reason that would make physical training unsafe
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special breathing muscle exercise program can improve thinking and memory in adults aged 60 and older. If you are generally healthy and can walk and communicate on your own, you may be able to join.
This study tests whether special breathing muscle exercises can improve thinking and memory in healthy young adults. Researchers will track how the training affects your brain performance over time.
This study tests whether a breathing muscle training program can help older adults improve their breathing strength and overall health. It is designed for people aged 65 and older who are generally healthy and able to go about their daily activities independently.
This trial tests a simple breathing exercise done for about 5–10 minutes each day for 8 weeks. It aims to see if this exercise can reduce your risk of dementia. If you are between 60 and 80 years old and have at least one risk factor for dementia, this study may be a fit for you.
This trial tests whether simple breathing exercises can improve memory and thinking skills in adults aged 65 and older. You would attend two sessions each week for 8 weeks.
This study tests whether breathing controlled low-oxygen air (through a disposable face mask) can improve brain function in people with mild cognitive impairment (MCI). You’d be randomly assigned to the real treatment or a sham (placebo-like) control, and you’d need multiple lab visits.
Hear when a new Mild Cognitive Impairment (MCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.